Scheduled imaging studies provide little help detecting relapse of aggressive lymphoma
Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, ...
Cancer
May 16, 2013 |
not rated yet |
0
Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer
May 13, 2013 |
5 / 5 (3) |
0
|
Searching for therapeutic synergy in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with ...
Cancer
May 01, 2013 |
not rated yet |
0
New strategy helps young lymphoma patients avoid radiation treatment
(HealthDay)—A new treatment approach may mean that young people with a form of lymphoma can go without radiation therapy, sparing them side effects or raised cancer risks down the road.
Cancer
Apr 10, 2013 |
5 / 5 (1) |
0
Heart surgery increases death risk for cancer survivors who had radiation
Cancer survivors who had chest radiation are nearly twice as likely to die in the years after having major heart surgery as similar patients who didn't have radiation, according to research in the American Heart Association ...
Cardiology
Apr 08, 2013 |
not rated yet |
0
Immunotherapy showed promising antileukemia activity in pediatric patients
Researchers using patients' own immune cells in an immunotherapy approach called "anti-CD19 chimeric antigen receptor (CAR) T-cell therapy," achieved responses in children whose acute lymphocytic leukemia (ALL) had returned ...
Cancer
Apr 07, 2013 |
5 / 5 (1) |
0
New type of deadly lymphoma identified
An international research team has identified a new type of deadly intestinal lymphoma that is particularly common in Asia. The team, led by clinician-scientists from the SingHealth Academic Healthcare Cluster, also developed ...
Cancer
Apr 01, 2013 |
5 / 5 (2) |
0
Researchers find NSAIDs help push stem cells into bloodstream prior to transplantation
(Medical Xpress)—A team of researchers at Indiana University's School of Medicine has found that giving meloxicam, a non-steroidal anti-inflammatory drug (NSAID), to people and baboons boosts the number of haematopoietic ...
Medical research
Mar 14, 2013 |
not rated yet |
0
|
Circulatory system mortality declining in Hodgkin's
(HealthDay)—Among patients treated for Hodgkin's lymphoma (HL), long-term excess mortality due to diseases of the circulatory system (DCS) is expected to continue to decline, according to research published ...
Cancer
Mar 09, 2013 |
not rated yet |
0
Small molecules in the blood might gauge radiation effects after exposure
Ohio State University cancer researchers have identified molecules in the bloodstream that might accurately gauge the likelihood of radiation illness after exposure to ionizing radiation.
Cancer
Feb 25, 2013 |
5 / 5 (1) |
0
|
Cured of cancer but in poor health
The majority of people afflicted with cancer now recover with treatment. Many of these, however, subsequently experience new health problems due to the cancer and/or the treatment. Norwegian researchers want to find out why.
Cancer
Feb 15, 2013 |
not rated yet |
0
High-dose Vorinostat effective at treating relapsed lymphomas
Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease. Reporting the results of a first-of-its-kind ...
Cancer
Feb 04, 2013 |
not rated yet |
0
Research: Lupus drugs carry no significant cancer risk for patients
People who take immunosuppressive drugs to treat lupus do not necessarily increase their cancer risk according to new research led by scientists at the Research Institute of the McGill University Health Centre (RI-MUHC). ...
Medications
Jan 24, 2013 |
not rated yet |
0
Epigenomic abnormalities predict patient survival in non-Hodgkins lymphoma
Think of the epigenome like a giant musical mixing board, turning up or down the expression of various genes. A University of Colorado Cancer Center study published today in the journal PLOS Genetics shows that in cancer ...
Genetics
Jan 10, 2013 |
not rated yet |
0
|
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's ...
Cancer
Dec 26, 2012 |
not rated yet |
0
|
